Usability Study of the Commercial Auto-injector Device and the New Auto-injector Device (SYDNEY) in Patients With High or Very High CV Risk With Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy

NCT03415178 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolaemia

Interventions

DRUG: Alirocumab SAR236553
DEVICE: Current auto-injector device (AI)
DEVICE: New auto-injector device (SYDNEY)
DRUG: Atorvastatin
DRUG: Rosuvastatin

Sponsor

Sanofi

Collaborators

[object Object]